Biodex

José Correia

Jacqueline Jozefonvicz

Marcel Jozefowicz

Laurent Sedel

Hervé Petite

Delphine Logeart-Avramoglou

Alain Meunier

Frédéric Chaubet

Rémi Huynh

Latifa Dahricorreia

Cinderella Blanchat

The invention concerns pharmaceutical compositions with wound healing or anti-complementary activity, and their uses, said compositions comprising, (1) at least a dextran derivative of general formula DMCBSu, a, b, and c respectively representing the degrees of substitution in the groups MC, B and Su, wherein a&#x2267;0.6, b=0 or &#x2267;0.1, and c=0 or ranges widely between 0.1 and 0.5 for a wound healing composition, and a&#x2267;0.3, b&#x2267;0.1 and c=0 or ranges widely between 0.1 and 0.4 for a composition with anti-complementary activity; (2) and at least a pharmaceutically acceptable carrier, said dextran derivative being present in a single unit dose or at a concentration adapted to the desired wound healing or anti-complementary activity.

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative

The invention concerns a biologically active material essentially comprising at least an insolubilized dextran derivative of general formula DMCBSUSand at least a growth factor having an activity on osteoarticular, dental and/or maxillofacial tissues, and the method for preparing same. The invention also concerns the uses of said biomaterial for preparing a repair or filing material, such as an implant, for osteoarticular, dental or maxillofacial applications and for preparing an orthopaedic, dental or maxillofacial prosthesis, and the prosthesis coated with said biologically active material.

Biomaterial based on an insolubilized dextran derivative and a growth factor

Growing community of inventors

Saint Amand les Eaux, France

José Correia